A Phase 2 Study of Vosoritide in Children with Idiopathic Short Stature
Status:
RECRUITING
Trial end date:
2036-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate i) the effect of multiple doses of vosoritide and ii) the effect of the therapeutic dose of vosoritide compared to human growth hormone (hGH), in children with idiopathic short stature (ISS).